Oslo, Norway, May 16, 2022 - Reference is made to the Annual General Meeting (AGM) in Nykode Therapeutics AS held on May 12, 2022, where the grant of share options to certain members of the Board was approved. A total of 425,000 share options with a strike price of NOK 31.90 per share have been granted in line with the terms set out in the minutes from the AGM. 
 
Further, a total of 1,450,987 share options have been granted to employees of Nykode Therapeutics AS under the companyâ€™s share option scheme, of which 839,646 share options have been granted to primary insiders. The share options will have a strike price of NOK 34.99 per share, have a five-year term and will vest equally over a four-year vesting period.
 
Please see further details in attached document.